Fundraising Fox
Biochange
Founded 2017 · 17 employees on LinkedIn · 1 known investors
Find your way into Biochange
Sign up to see every warm intro you have to Biochange
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biochange team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Biochange do?
- BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.
- Who are Biochange's investors?
- Biochange's investors include quadraScope Venture Fund.